Wee1

Wee1 (EC 2.7.10.2) is a protein kinase, regulates the G2 checkpoint in response to DNA-damage. Preclinical studies have elucidated the role of wee1 in DNA-damage repair and the stabilization of replication forks, supporting the validity of wee1 inhibition as a viable therapeutic target in cancer. Wee1 belongs to a family of protein kinases involved in the terminal phosphorylation and inactivation of cyclin-dependent-kinase 1-bound cyclin B. It is the major kinase responsible for the inhibitory phosphorylation of the tyrosine15 residue on Cdk1/Cdc2, near its ATP-binding pocket, and plays a critical role in the proper timing of cell division by controlling the entry into mitosis and DNA-replication during S phase. Recent evidence demonstrates that wee1 is also involved in the coordination of DNA-replication and the maintenance of stalled replication forks through regulation of cyclin-dependent kinase 2 (Cdk2)[1].


[1] K. Do et al. Wee1 kinase as a target for cancer therapy. Cell Cycle. 2013, 12, 3159-3164.

3 Item(s)

per page
Axon ID Name Description From price
3759 (aR)-RP-6306 (aR)-enantiomer of RP-6306 (Axon 3668); PKMYT1 inhibitor €180.00
1494 MK 1775 Wee1 kinase inhibitor €80.00
3668 RP-6306 First-in-class, potent, selective, and orally bioavailable PKMYT1 inhibitor €140.00

3 Item(s)

per page
Please wait...